Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7452 USD | -3.06% | -0.64% | +1.39% |
2023 | NGM Biopharmaceuticals Says Phase 2b Trial of Potential Cirrhosis Treatment Meets Primary Endpoint | MT |
2023 | Alpine 4 Holdings, Inc.(NasdaqCM:ALPP) dropped from S&P Global BMI Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+1.39% | 20.77M | |
+11.65% | 109B | |
-4.18% | 28.24B | |
+11.79% | 22.19B | |
-13.93% | 18.29B | |
-7.70% | 17.4B | |
+14.29% | 16.08B | |
-9.32% | 11.55B | |
-1.88% | 10.45B | |
-2.81% | 9.65B |
- Stock Market
- Equities
- ALPP Stock
- News Alpine 4 Holdings, Inc.
- Sector Update: Energy